Mode
Text Size
Log in / Sign up

Protein nutritional support in critically ill adults shows heterogeneous mortality benefits and potential harm from very high early dosesWhy ICU Patients Need More Protein, But Not Too Much

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider current guidelines supporting progressive enteral-first protein delivery at 1.2–1.3 g/kg/day after hemodynamic stabilization.

This narrative review assesses protein nutritional support and supplementation strategies for critically ill adults, specifically addressing populations with sepsis, severe burns, and general critical illness. The review highlights that evidence regarding specific protein sources, functional amino acids, and metabolic modulators remains heterogeneous. Randomized trials and meta-analyses do not show a uniform mortality benefit from higher protein provision, indicating that the clinical picture is complex and not fully resolved.

The primary outcomes examined include mortality, functional impairment, negative nitrogen balance, skeletal muscle breakdown, wound healing, metabolic tolerance, and acute kidney injury. Results indicate that mortality benefit from higher protein provision is not uniform across studies. Conversely, there is a potential for harm associated with very high early doses, which may be detrimental in specific patient subgroups.

Safety and tolerability profiles vary; while serious adverse events were not explicitly reported in the summary data, poor metabolic tolerance was noted in selected patients. The review cautions that very high early doses may be harmful. Key limitations include the heterogeneity of evidence and the lack of uniform mortality benefits observed in rigorous trials.

Practice relevance suggests that current guidelines generally support progressive enteral-first protein delivery after hemodynamic stabilization, targeting at least 1.2–1.3 g/kg/day. Higher targets are more consistently justified in severe burns. Clinicians should interpret findings conservatively, recognizing that evidence remains heterogeneous and that causality is not definitively established for mortality benefits.

A body in crisis burns its own muscle

When a person becomes critically ill, something quiet happens beneath the surface. Their body starts breaking down muscle to fuel the emergency response.

Sepsis, severe burns, major trauma — all of them trigger this process. Days in the ICU can melt away muscle that took years to build.

That muscle loss is not just about looking thin. It hurts breathing, slows recovery, and makes it harder to walk, cook, and care for yourself weeks or months after the hospital stay ends.

ICUs worldwide keep patients alive through crises that would have killed them a generation ago. Survival rates have climbed. But recovery after survival has been harder to crack.

Many ICU survivors spend months or years regaining strength. Some never fully bounce back. Doctors want tools that shorten that painful recovery, and protein is one of the oldest and simplest tools on the shelf.

Old view vs. a more nuanced view

The old thinking was simple. Sick people need more protein. The sicker they are, the more they need.

For a while, that pushed hospitals to deliver aggressive amounts of protein through feeding tubes and IVs, sometimes within the first day or two of admission.

The new thinking, laid out in this review, is more careful. More is not always better. And timing matters as much as amount.

How it works, in plain English

Think of muscle as a savings account. In everyday life, you put in and take out small amounts. The balance stays roughly even.

Critical illness drains the account fast. To refill it, the body needs deposits. Protein is the deposit. Amino acids in the protein become the building blocks for new muscle.

But here is the part that is newer. If you try to make a huge deposit before the body is ready to use it, some of that protein becomes waste. It stresses the kidneys and the body's clean-up systems without building muscle.

So doctors now think about pacing. Start lower. Build up as the patient stabilizes. Match the supply to the body's actual ability to use it.

What current guidelines say

Most guidelines recommend starting protein once a patient is stable on the ICU's basic life-support. That usually means after blood pressure is under control.

The target is usually at least 1.2 to 1.3 grams of protein per kilogram of body weight per day. That is roughly double what most healthy adults need.

Burn patients often need more. Their bodies stay in a revved-up state for weeks while wounds heal. Burns also lose proteins through weeping skin, which must be replaced.

Here is what the evidence says

Reviews of multiple randomized trials show protein support helps, but the benefit on survival is not dramatic. Patients may recover function better. They may leave the ICU a bit sooner. Mortality, the hardest outcome to move, does not always budge.

A few studies even hint that very high early doses can cause harm in certain patients. People with acute kidney injury or those who are not yet stable may do worse when protein is pushed too fast.

This is where things get interesting.

The best protein strategy may not be one number for every ICU patient. It may be a custom plan based on what kind of illness they have, how their kidneys are working, and how their body is responding.

Sepsis looks different from burns. A 22-year-old after a car crash looks different from an 80-year-old with pneumonia. The review argues we should stop treating them all the same.

How the researchers read it

The authors of the review acknowledge that protein is powerful but imperfect. They push for richer research that tracks not just survival but also muscle strength, daily function, and long-term quality of life.

They also caution that special proteins, supplements, and amino acid cocktails have mixed evidence. Some may help. Some may not. Few are clearly game-changing.

If you or a loved one end up in the ICU, know that what gets fed matters. Ask the care team about the nutrition plan. Ask when protein will be started. Ask what the target is.

For most family members, nutrition goals feel mysterious. They are not. The ICU team can explain them in plain language.

If you are a caregiver helping a survivor recover at home, keep protein in the diet. Eggs, fish, beans, dairy, poultry. Good protein plus physical therapy is often what rebuilds strength.

The limits

Most of the evidence comes from short-term studies. Long-term outcomes, like what someone can do a year after ICU discharge, are harder to measure and less often studied.

Patients in trials also tend to be healthier than the typical ICU crowd. That can make trial results look better than what happens in real hospitals.

The review calls for phenotype-specific trials. Plain English: studies that group patients by illness type, severity, and metabolic fingerprint. That way doctors learn which exact patients benefit most from which protein dose.

Bedside tools that measure muscle loss in real time, like ultrasound or impedance, are getting better too. In a few years, protein plans may be tuned day by day to what each patient's body is actually doing.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Protein metabolic derangement is a hallmark of critical illness and contributes to adverse outcomes and delayed recovery. This narrative review synthesises current evidence on protein metabolism, requirement assessment, and supplementation strategies in critically ill adults, with emphasis on sepsis and severe burns as representative hypercatabolic phenotypes. Sepsis and major burns are characterised by accelerated skeletal muscle breakdown, negative nitrogen balance, and sustained functional impairment. Current guidelines generally support progressive enteral-first protein delivery after haemodynamic stabilisation, targeting at least 1.2–1.3 g/kg/day, whereas higher targets are more consistently justified in severe burns because of prolonged hypermetabolism, exudative losses, and wound-healing demands. However, randomised trials and meta-analyses do not show a uniform mortality benefit from higher protein provision, and very high early doses may be harmful in selected patients, particularly those with acute kidney injury or poor metabolic tolerance. Evidence for specific protein sources, functional amino acids, micronutrients, probiotics, and metabolic modulators remains heterogeneous. Future research should define phenotype-specific protein strategies using metabolic, structural, functional, and long-term patient-centred outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.